Jeffrey P. Henderson
Research Subjects
Jeffrey P. Henderson has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Chia S. Hung
Center for Women's Infectious Diseases Research, Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA
5 shared publicationsEun-Ik Koh
Infectious Diseases, Washington University School of Medicine, United States
5 shared publicationsJan R. Crowley
The Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110
4 shared publicationsAnn E. Stapleton
Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA
3 shared publicationsDaryl E. Giblin
Department of Chemistry, Washington University, St. Louis, Missouri, USA
3 shared publicationsKaveri S. Parker
Center for Women's Infectious Diseases Research, Washington University in St. Louis School of Medicine, St. Louis, MO, United States; Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, MO, United States; Department of Internal Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO, United States
3 shared publications
Latest Publications
- Open Access
- 1 September 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (39) , 14953-14961
Uropathogenic enterobacteria use the yersiniabactin metallophore system to acquire nickel
- 1 September 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (39) , 14953-14961
Open AccessUropathogenic enterobacteria use the yersiniabactin metallophore system to acquire nickel
- Open Access
- 25 September 2017
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 127 (11) , 4018-4030
Enterobacteria secrete an inhibitor of Pseudomonas virulence during clinical bacteriuria
Escherichia coli and other Enterobacteriaceae are among the most common pathogens of the human urinary tract. Among the genetic gains of function associated with urinary E. coli isolates is the Yersinia high pathogenicity island (HPI), which directs the biosynthesis of yersiniabactin (Ybt), a virulence-associated metallophore. Using a metabolomics approach, we found that E. coli and other Enterobacteriaceae expressing the Yersinia HPI also secrete escherichelin, a second metallophore whose chemical structure matches a known synthetic inhibitor of the virulence-associated pyochelin siderophore system in Pseudomonas aeruginosa. We detected escherichelin during clinical E. coli urinary tract infection (UTI) and experimental human colonization with a commensal, potentially probiotic E. coli bacteriuria strain. Escherichelin production by colonizing enterobacteria may help human hosts resist opportunistic infections by Pseudomonas and other pyochelin-expressing bacteria. This siderophore-based mechanism of microbial antagonism may be one of many elements contributing to the protective effects of the human microbiome. Future UTI-preventive probiotic strains may benefit by retaining the escherichelin biosynthetic capacity of the Yersinia HPI while eliminating the Ybt biosynthetic capacity.
- 25 September 2017
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 127 (11) , 4018-4030
Open AccessEnterobacteria secrete an inhibitor of Pseudomonas virulence during clinical bacteriuria
Escherichia coli and other Enterobacteriaceae are among the most common pathogens of the human urinary tract. Among the genetic gains of function associated with urinary E. coli isolates is the Yersinia high pathogenicity island (HPI), which directs the biosynthesis of yersiniabactin (Ybt), a virulence-associated metallophore. Using a metabolomics approach, we found that E. coli and other Enterobacteriaceae expressing the Yersinia HPI also secrete escherichelin, a second metallophore whose chemical structure matches a known synthetic inhibitor of the virulence-associated pyochelin siderophore system in Pseudomonas aeruginosa. We detected escherichelin during clinical E. coli urinary tract infection (UTI) and experimental human colonization with a commensal, potentially probiotic E. coli bacteriuria strain. Escherichelin production by colonizing enterobacteria may help human hosts resist opportunistic infections by Pseudomonas and other pyochelin-expressing bacteria. This siderophore-based mechanism of microbial antagonism may be one of many elements contributing to the protective effects of the human microbiome. Future UTI-preventive probiotic strains may benefit by retaining the escherichelin biosynthetic capacity of the Yersinia HPI while eliminating the Ybt biosynthetic capacity.
- Open Access
- 24 July 2017
- Published by Springer Nature in Nature Chemical Biology
- Vol. 13 (9) , 1016-1021
Copper import in Escherichia coli by the yersiniabactin metallophore system
Under high-copper conditions, yersiniabactin (Ybt) binds copper (Cu) to prevent toxicity. Ybt is now shown to mediate Cu import under low-Cu conditions through formation of a Cu(II)-Ybt complex resulting in metalation of a Cu-requiring enzyme. Copper plays a dual role as a nutrient and a toxin during bacterial infections. While uropathogenic Escherichia coli (UPEC) strains can use the copper-binding metallophore yersiniabactin (Ybt) to resist copper toxicity, Ybt also converts bioavailable copper to Cu(II)–Ybt in low-copper conditions. Although E. coli have long been considered to lack a copper import pathway, we observed Ybt-mediated copper import in UPEC using canonical Fe(III)–Ybt transport proteins. UPEC removed copper from Cu(II)–Ybt with subsequent re-export of metal-free Ybt to the extracellular space. Copper released through this process became available to an E. coli cuproenzyme (the amine oxidase TynA), linking this import pathway to a nutrient acquisition function. Ybt-expressing E. coli thus engage in nutritional passivation, a strategy of minimizing a metal ion's toxicity while preserving its nutritional availability. Copper acquisition through this process may contribute to the marked virulence defect of Ybt-transport-deficient UPEC.
- 24 July 2017
- Published by Springer Nature in Nature Chemical Biology
- Vol. 13 (9) , 1016-1021
Open AccessCopper import in Escherichia coli by the yersiniabactin metallophore system
Under high-copper conditions, yersiniabactin (Ybt) binds copper (Cu) to prevent toxicity. Ybt is now shown to mediate Cu import under low-Cu conditions through formation of a Cu(II)-Ybt complex resulting in metalation of a Cu-requiring enzyme. Copper plays a dual role as a nutrient and a toxin during bacterial infections. While uropathogenic Escherichia coli (UPEC) strains can use the copper-binding metallophore yersiniabactin (Ybt) to resist copper toxicity, Ybt also converts bioavailable copper to Cu(II)–Ybt in low-copper conditions. Although E. coli have long been considered to lack a copper import pathway, we observed Ybt-mediated copper import in UPEC using canonical Fe(III)–Ybt transport proteins. UPEC removed copper from Cu(II)–Ybt with subsequent re-export of metal-free Ybt to the extracellular space. Copper released through this process became available to an E. coli cuproenzyme (the amine oxidase TynA), linking this import pathway to a nutrient acquisition function. Ybt-expressing E. coli thus engage in nutritional passivation, a strategy of minimizing a metal ion's toxicity while preserving its nutritional availability. Copper acquisition through this process may contribute to the marked virulence defect of Ybt-transport-deficient UPEC.
- Open Access
- 1 December 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (50) , 25901-25910
Human Metabolome-derived Cofactors Are Required for the Antibacterial Activity of Siderocalin in Urine
- 1 December 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (50) , 25901-25910
Open AccessHuman Metabolome-derived Cofactors Are Required for the Antibacterial Activity of Siderocalin in Urine
- Open Access
- 1 May 2016
- Published by Elsevier in EBioMedicine
- Vol. 7, 167-174
Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Cohort
- 1 May 2016
- Published by Elsevier in EBioMedicine
- Vol. 7, 167-174
Open AccessUrinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Cohort
- 1 May 2016
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 84 (5) , 1312-1319
The Yersiniabactin-Associated ATP Binding Cassette Proteins YbtP and YbtQ Enhance Escherichia coli Fitness during High-Titer Cystitis
The Yersinia high-pathogenicity island (HPI) is common to multiple virulence strategies used by Escherichia coli strains associated with urinary tract infection (UTI). Among the genes in this island are ybtP and ybtQ , encoding distinctive ATP binding cassette (ABC) proteins associated with iron(III)-yersiniabactin import in Yersinia pestis . In this study, we compared the impact of ybtPQ on a model E. coli cystitis strain during in vitro culture and experimental murine infections. A ybtPQ -null mutant exhibited no growth defect under standard culture conditions, consistent with nonessentiality in this background. A growth defect phenotype was observed and genetically complemented in vitro during iron(III)-yersiniabactin-dependent growth. Following inoculation into the bladders of C3H/HEN and C3H/HeOuJ mice, this strain exhibited a profound, 10 6 -fold competitive infection defect in the subgroup of mice that progressed to high-titer bladder infections. These results identify a virulence role for YbtPQ in the highly inflammatory microenvironment characteristic of high-titer cystitis. The profound competitive defect may relate to the apparent selection of Yersinia HPI-positive E. coli in uncomplicated clinical UTIs.
- 1 May 2016
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 84 (5) , 1312-1319
The Yersiniabactin-Associated ATP Binding Cassette Proteins YbtP and YbtQ Enhance Escherichia coli Fitness during High-Titer Cystitis
The Yersinia high-pathogenicity island (HPI) is common to multiple virulence strategies used by Escherichia coli strains associated with urinary tract infection (UTI). Among the genes in this island are ybtP and ybtQ , encoding distinctive ATP binding cassette (ABC) proteins associated with iron(III)-yersiniabactin import in Yersinia pestis . In this study, we compared the impact of ybtPQ on a model E. coli cystitis strain during in vitro culture and experimental murine infections. A ybtPQ -null mutant exhibited no growth defect under standard culture conditions, consistent with nonessentiality in this background. A growth defect phenotype was observed and genetically complemented in vitro during iron(III)-yersiniabactin-dependent growth. Following inoculation into the bladders of C3H/HEN and C3H/HeOuJ mice, this strain exhibited a profound, 10 6 -fold competitive infection defect in the subgroup of mice that progressed to high-titer bladder infections. These results identify a virulence role for YbtPQ in the highly inflammatory microenvironment characteristic of high-titer cystitis. The profound competitive defect may relate to the apparent selection of Yersinia HPI-positive E. coli in uncomplicated clinical UTIs.
- Open Access
- 24 July 2015
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 1 (11) , 523-532
Network Analysis Reveals Sex- and Antibiotic Resistance-Associated Antivirulence Targets in Clinical Uropathogens
Increasing antibiotic resistance among uropathogenic Escherichia coli (UPEC) is driving interest in therapeutic targeting of nonconserved virulence factor (VF) genes. The ability to formulate efficacious combinations of antivirulence agents requires an improved understanding of how UPEC deploy these genes. To identify clinically relevant VF combinations, we applied contemporary network analysis and biclustering algorithms to VF profiles from a large, previously characterized inpatient clinical cohort. These mathematical approaches identified four stereotypical VF combinations with distinctive relationships to antibiotic resistance and patient sex that are independent of traditional phylogenetic grouping. Targeting resistance- or sex-associated VFs based upon these contemporary mathematical approaches may facilitate individualized anti-infective therapies and identify synergistic VF combinations in bacterial pathogens.
- 24 July 2015
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 1 (11) , 523-532
Open AccessNetwork Analysis Reveals Sex- and Antibiotic Resistance-Associated Antivirulence Targets in Clinical Uropathogens
Increasing antibiotic resistance among uropathogenic Escherichia coli (UPEC) is driving interest in therapeutic targeting of nonconserved virulence factor (VF) genes. The ability to formulate efficacious combinations of antivirulence agents requires an improved understanding of how UPEC deploy these genes. To identify clinically relevant VF combinations, we applied contemporary network analysis and biclustering algorithms to VF profiles from a large, previously characterized inpatient clinical cohort. These mathematical approaches identified four stereotypical VF combinations with distinctive relationships to antibiotic resistance and patient sex that are independent of traditional phylogenetic grouping. Targeting resistance- or sex-associated VFs based upon these contemporary mathematical approaches may facilitate individualized anti-infective therapies and identify synergistic VF combinations in bacterial pathogens.
- Open Access
- 1 July 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (31) , 18967-18974
Microbial Copper-binding Siderophores at the Host-Pathogen Interface
- 1 July 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (31) , 18967-18974
Open AccessMicrobial Copper-binding Siderophores at the Host-Pathogen Interface
- Open Access
- 1 June 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (26) , 15949-15960
Human Urinary Composition Controls Antibacterial Activity of Siderocalin*
- 1 June 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (26) , 15949-15960
Open AccessHuman Urinary Composition Controls Antibacterial Activity of Siderocalin*
- Open Access
- 1 January 2015
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 7 (6) , 1011-1022
Metal selectivity by the virulence-associated yersiniabactin metallophore system
Metal–yersiniabactin complexes are transported intact through the outer membrane receptor, FyuA, in a TonB-dependent manner in uropathogenicEscherichia coli.
- 1 January 2015
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 7 (6) , 1011-1022
Open AccessMetal selectivity by the virulence-associated yersiniabactin metallophore system
Metal–yersiniabactin complexes are transported intact through the outer membrane receptor, FyuA, in a TonB-dependent manner in uropathogenicEscherichia coli.